Ranked by market cap
| # | Company | Ticker | Sector | Market Cap | Screening basis |
|---|---|---|---|---|---|
| 1 | SAMSUNG BIOLOGICS | 207940.KS | Healthcare | $62.3T | Research-based |
| 2 | Celltrion | 068270.KS | Healthcare | $39.8T | Research-based |
| 3 | HOYA CORP | 7741.T | Healthcare | $8.9T | Research-based |
| 4 | AstraZeneca PLC Ordinary Shares | AZN | Healthcare | $286.8B | Research-based |
| 5 | ROCHE I | RO.SW | Healthcare | $269.2B | Research-based |
| 6 | ROCHE PS | ROP.SW | Healthcare | $262.2B | Research-based |
| 7 | NOVARTIS N | NOVN.SW | Healthcare | $227.1B | Research-based |
| 8 | Vertex Pharmaceuticals Incorporated - Common Stock | VRTX | Healthcare | $109.2B | Research-based |
| 9 | Medtronic plc. Ordinary Shares | MDT | Healthcare | $98.8B | Research-based |
| 10 | McKesson Corporation Common Stock | MCK | Healthcare | $89.8B | Research-based |
| 11 | Regeneron Pharmaceuticals, Inc. - Common Stock | REGN | Healthcare | $68.1B | Research-based |
| 12 | CSL FPO [CSL] | CSL.AX | Healthcare | $47.2B | Research-based |
| 13 | Edwards Lifesciences Corporation Common Stock | EW | Healthcare | $46.8B | Research-based |
| 14 | IDEXX Laboratories, Inc. - Common Stock | IDXX | Healthcare | $43.7B | Research-based |
| 15 | RESMED CDI 10:1 [RMD] | RMD.AX | Healthcare | $42.4B | Research-based |
| 16 | Alnylam Pharmaceuticals, Inc. - Common Stock | ALNY | Healthcare | $39.9B | Research-based |
| 17 | GALDERMA GROUP N | GALD.SW | Healthcare | $36.3B | Research-based |
| 18 | SIGMAHEALT FPO [SIG] | SIG.AX | Healthcare | $33.0B | Research-based |
| 19 | Waters Corporation Common Stock | WAT | Healthcare | $32.7B | Research-based |
| 20 | Revolution Medicines, Inc. - Common Stock | RVMD | Healthcare | $32.0B | Research-based |
| 21 | Insmed Inc | INSM | Healthcare | $31.3B | ETF-tracked |
| 22 | Royalty Pharma plc - Class A Ordinary Shares | RPRX | Healthcare | $30.6B | Research-based |
| 23 | ResMed Inc. Common Stock | RMD | Healthcare | $29.4B | Research-based |
| 24 | Biogen Inc. - Common Stock | BIIB | Healthcare | $27.7B | Research-based |
| 25 | DexCom, Inc. - Common Stock | DXCM | Healthcare | $27.6B | Research-based |